Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

摘要

BackgroundThe use of immune checkpoint inhibitors is increasing in cancer therapy today. It is critical that treatment teams become familiar with the organ systems potentially impacted by immune-related adverse events associated with these drugs. Here, we report adverse skeletal effects of immunotherapy, a phenomenon not previously described.